Eclipsebio will unveil eSENSE dsRNA at the RNA Leaders USA Congress on September 4, 2024. About Eclipsebio. Eclipsebio is a private biotechnology company headquartered in San Diego developing ...

It also shows a preference for binding with dsRNA over dsDNA, which is an important selective process for future applications in a cellular environment where RNA and DNA co-exist.

The AVIPure dsRNA Clear resin launch follows last week’s formal completion by Repligen of its acquisition of Tantti Laboratory Inc., announced on July 29, 2024.. Olivier Loeillot, President and ...

It also shows a preference for binding with dsRNA over dsDNA, which is an important selective process for future applications in a cellular environment where RNA and DNA co-exist.

After many experiments, the team settled on using two different fluorescent dyes—one for labeling RNA and another for DNA. Because of the double-stranded structure of dsRNA, the team reasoned ...

Repligen announced the launch of AVIPure dsRNA Clear OPUS columns, a solution designed to simplify and enhance the production of mRNA therapeutics and vaccines.This novel affinity chromatography ...

The EPA was the last of three agencies—along with the FDA and USDA—that signed off on the safety of DvSnf7 dsRNA. Critics often point to a 2011 paper to question the safety of tinkering with RNAi.

WILMINGTON, DE – March 8, 2016 – DeNovix Inc., a developer and manufacturer of life science instrumentation and assays launches the Ultra High Sensitivity dsDNA fluorescence quantification assay.

Honey bees (Apis mellifera) are essential crop pollinators worldwide, but are threatened by colony losses linked to the spread of parasites and pathogens, the authors explained.Figures suggest ...

Eclipsebio’s eSENSE dsRNA™ uses next-generation sequencing to provide both quantification of contaminating dsRNA and the identification of RNA sequences and structures that lead to dsRNA ...